Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen A Seow

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Molecular Cancer Therapeutics|May 2, 2006
Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazineKimiko Ishiguro, Helen A Seow, Philip G Penketh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2005
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cellsHelen A Seow, Philip G Penketh, Krishnamurthy Shyam, et al.
Oncology Research|January 18, 2006
The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activationRaymond P Baumann, Helen A Seow, Krishnamurthy Shyam, et al.
Radiation Research|October 31, 2008
Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cellsRaymond P Baumann, Philip G Penketh, Helen A Seow, et al.
Leukemia Research|May 16, 2008
Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating speciesPhilip G Penketh, Raymond P Baumann, Kimiko Ishiguro, et al.
The Journal of Biological Chemistry|May 25, 2004
Nuclear overexpression of NAD(P)H:quinone oxidoreductase 1 in Chinese hamster ovary cells increases the cytotoxicity of mitomycin C under aerobic and hypoxic conditionsHelen A Seow, Philip G Penketh, Michael F Belcourt, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2012
Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferaseRui Zhu, Helen A Seow, Raymond P Baumann, et al.
Molecular Pharmacology|November 18, 2004
Nuclear localization of NADPH:cytochrome c (P450) reductase enhances the cytotoxicity of mitomycin C to Chinese hamster ovary cellsHelen A Seow, Michael F Belcourt, Philip G Penketh, et al.
International Journal of Radiation Biology|November 25, 2011
Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumorsSara Rockwell, Yanfeng Liu, Helen A Seow, et al.
Autism Research : Official Journal of the International Society for Autism Research|March 17, 2023
Evaluation of clinical assessments of social abilities for use in autism clinical trials by the autism biomarkers consortium for clinical trialsSusan Faja, Maura Sabatos-DeVito, Aksheya Sridhar, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Molecular Cancer Therapeutics|May 2, 2006
Mode of action of the chloroethylating and carbamoylating moieties of the prodrug cloretazineKimiko Ishiguro, Helen A Seow, Philip G Penketh, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 21, 2005
1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cellsHelen A Seow, Philip G Penketh, Krishnamurthy Shyam, et al.
Oncology Research|January 18, 2006
The antineoplastic efficacy of the prodrug Cloretazine is produced by the synergistic interaction of carbamoylating and alkylating products of its activationRaymond P Baumann, Helen A Seow, Krishnamurthy Shyam, et al.
Radiation Research|October 31, 2008
Generation of oxygen deficiency in cell culture using a two-enzyme system to evaluate agents targeting hypoxic tumor cellsRaymond P Baumann, Philip G Penketh, Helen A Seow, et al.
Leukemia Research|May 16, 2008
Lethality to leukemia cell lines of DNA interstrand cross-links generated by Cloretazine derived alkylating speciesPhilip G Penketh, Raymond P Baumann, Kimiko Ishiguro, et al.
The Journal of Biological Chemistry|May 25, 2004
Nuclear overexpression of NAD(P)H:quinone oxidoreductase 1 in Chinese hamster ovary cells increases the cytotoxicity of mitomycin C under aerobic and hypoxic conditionsHelen A Seow, Philip G Penketh, Michael F Belcourt, et al.
Bioorganic & Medicinal Chemistry Letters|August 31, 2012
Design of a hypoxia-activated prodrug inhibitor of O6-alkylguanine-DNA alkyltransferaseRui Zhu, Helen A Seow, Raymond P Baumann, et al.
Molecular Pharmacology|November 18, 2004
Nuclear localization of NADPH:cytochrome c (P450) reductase enhances the cytotoxicity of mitomycin C to Chinese hamster ovary cellsHelen A Seow, Michael F Belcourt, Philip G Penketh, et al.
International Journal of Radiation Biology|November 25, 2011
Preclinical evaluation of Laromustine for use in combination with radiation therapy in the treatment of solid tumorsSara Rockwell, Yanfeng Liu, Helen A Seow, et al.
Autism Research : Official Journal of the International Society for Autism Research|March 17, 2023
Evaluation of clinical assessments of social abilities for use in autism clinical trials by the autism biomarkers consortium for clinical trialsSusan Faja, Maura Sabatos-DeVito, Aksheya Sridhar, et al.
Pageof 1